Weekly B12 Dosing
For treating vitamin B12 deficiency without neurological involvement, administer hydroxocobalamin 1 mg intramuscularly three times per week for 2 weeks, followed by lifelong maintenance of 1 mg intramuscularly every 2-3 months. 1
Treatment Algorithm Based on Clinical Presentation
Acute Treatment Phase (First 2 Weeks)
Without Neurological Symptoms:
- Hydroxocobalamin 1 mg IM three times weekly for 2 weeks 1
- This translates to approximately 3 mg total per week during initial treatment
With Neurological Involvement:
- Hydroxocobalamin 1 mg IM on alternate days until no further improvement 1
- Seek urgent specialist consultation from neurology and hematology 1
- Critical pitfall: Neurological symptoms include unexplained sensory/motor changes, gait disturbances, or cognitive decline—these require aggressive treatment to prevent irreversible spinal cord damage (subacute combined degeneration)
Maintenance Phase (Lifelong)
After completing the acute treatment phase:
- 1 mg hydroxocobalamin IM every 2-3 months for life 1
- For patients with neurological involvement who have stabilized: 1 mg IM every 2 months 1
Critical Safety Considerations
Never give folic acid before treating B12 deficiency 1—this can mask the anemia while allowing irreversible neurological damage to progress. The guidelines emphasize this repeatedly as it represents a serious clinical error with permanent consequences.
Alternative Dosing Strategies
While the guideline-recommended approach uses intramuscular injections, research evidence suggests alternative weekly oral/sublingual regimens may be effective for maintenance in patients without severe malabsorption:
- Sublingual: 350 μg weekly was shown to restore adequate B12 status in vegetarians/vegans with marginal deficiency 2
- Oral: 2000 μg weekly is commonly used but may not be superior to lower doses due to absorption limitations 2
However, these oral alternatives are not appropriate for initial treatment of confirmed deficiency, especially with neurological symptoms—intramuscular administration remains the standard of care per guidelines 1.
Monitoring Requirements
During initial treatment (days 5-7 and ongoing):
- Monitor serum potassium closely in first 48 hours 3
- Check hematocrit and reticulocyte counts 3
- Recheck B12 levels and related metabolic markers 4
The evidence strongly supports the intramuscular route for treating established deficiency because it bypasses absorption issues related to intrinsic factor deficiency, malabsorption, or gastric pathology that commonly cause B12 deficiency in the first place 3.